Drug-labels.com Search Menu

Trizivir: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Post Market
Strength:
300 mg / 150 mg / 300 mg

Patient Medication Information: uses, side effects, how to take - Trizivir

ABOUT THIS MEDICATION

What the medication is used for:

The Human Immunodeficiency Virus (HIV) is a retrovirus (a type of virus). Infection with HIV damages the immune system and can lead to Acquired Immune Deficiency Syndrome (AIDS) and other related illnesses.

TRIZIVIR belongs to a group of antiretroviral medicines called nucleoside analogue reverse transcriptase inhibitors (NRTIs), and is used in combination with other antiretrovirals to treat Human Immunodeficiency Virus (HIV) infection.

What it does:

TRIZIVIR does not cure HIV, but helps to prevent further damage to the immune system by slowing down production of new viruses. You must be sure to be seen regularly by your health care provider.

TRIZIVIR also increases the CD4 cell count in your blood. CD4 cells are a type of white blood cells that are important in helping your body fight infection.

When it should not be used:

TRIZIVIR should not be taken if:

  • you previously had an allergic reaction (hypersensitivity) to the active ingredient abacavir, which is also included in medicines called ZIAGEN, KIVEXA and TRIUMEQ (see What the important nonmedicinal ingredients are).
  • you previously had an allergic reaction to the active ingredient lamivudine which is included in medicines called 3TC, COMBIVIR or KIVEXA or zidovudine which is included in a medicine called RETROVIR or any of the other ingredients found in TRIZIVIR (see What the important nonmedicinal ingredients are).
  • you have liver disease.
  • you have a very low red blood cell count (anemia) or very low white blood cell count (neutropenia).

What the medicinal ingredient is:

TRIZIVIR is a treatment that contains a fixed dose combination of three active ingredients that are currently available as separate medicines: ZIAGEN (abacavir sulfate), 3TC (lamivudine) and RETROVIR (zidovudine). Each TRIZIVIR tablet contains 300 mg abacavir, 150 mg of lamivudine and 300 mg zidovudine.

What the important nonmedicinal ingredients are:

Each TRIZIVIR tablet contains the following nonmedicinal ingredients: hydroxypropyl methyl cellulose, indigotine aluminum lake, iron oxide yellow, magnesium stearate, microcrystalline cellulose, polyethylene glycol, sodium starch glycolate, and titanium dioxide.

What dosage forms it comes in:

TRIZIVIR tablets are blue/green, capsule-shaped, film-coated tablets imprinted with GX LL1 on one face, containing 300 mg abacavir as abacavir sulfate, 150 mg lamivudine and 300 mg zidovudine. Available in bottles of 60.

WARNINGS AND PRECAUTIONS

Hypersensitivity Reaction

You should be screened for the HLA-B*5701 gene variation prior to starting or re-starting treatment with TRIZIVIR. Patients who have the HLA-B*5701 gene variation have a high risk of developing a hypersensitivity reaction (serious allergic reaction) to abacavir, which is in the drug TRIZIVIR. This hypersensitivity reaction can be life threatening if you continue to take TRIZIVIR (see Important Information on Hypersensitivity Reactions).

Build-up of acid in your blood (lactic acidosis) and swollen and fatty liver:

Lactic acidosis (too much acid in the blood) and swollen and fatty liver (hepatomegaly with steatosis), including fatal cases, have been reported using nucleoside analogues alone or in combination. If you suffer symptoms (See Serious Side Effects Table), contact your doctor.

If you have a hepatitis B infection, you should not stop taking TRIZIVIR without instructions from your doctor as your hepatitis may worsen or reoccur. Your doctor will monitor your conditions for several months after stopping treatment with TRIZIVIR.

Important Information on Hypersensitivity Reactions

If you get two or more of the following groups of symptoms while taking TRIZIVIR contact your doctor immediately to find out if you should stop taking TRIZIVIR:

SYMPTOM(S)
Group 1Fever
Group 2Rash
Group 3Nausea, vomiting, diarrhea, or abdominal (stomach area) pain
Group 4Generally ill feeling, extreme tiredness or achiness
Group 5Shortness of breath, cough or sore throat

A list of these symptoms is on the Warning Card provided by your pharmacist. You should carry this Warning Card with you at all times. If you notice these symptoms while taking TRIZIVIR, call your doctor immediately. Your doctor may advise you to stop taking TRIZIVIR.

If you stop TRIZIVIR because of a serious allergic reaction, never take TRIZIVIR or any other medicine containing abacavir (such as ZIAGEN, KIVEXA or TRIUMEQ) again, regardless of whether you have the HLA-B*5701 gene variation or not. Within hours you may experience a life threatening lowering of your blood pressure or death. If you stop TRIZIVIR for any other reason, even for a few days, and you are not allergic to TRIZIVIR, talk with your doctor before taking it again. Taking TRIZIVIR again may cause a serious allergic or life-threatening reaction, even if you never had an allergic reaction to it before.

If your healthcare provider tells you that you can take TRIZIVIR, again, start taking it when you are around medical help or people who can call a doctor if you need one.

Occasionally, reactions have developed in people who start taking abacavir again, and had only one symptom on the Warning Card before they stopped taking it.

If you are hypersensitive to TRIZIVIR, return all your unused TRIZIVIR tablets for safe disposal. Ask your doctor or pharmacist for advice.

Before you use TRIZIVIR, talk to your doctor or pharmacist:

  • About all your medicines and medical conditions
  • If you have kidney or liver disease (including hepatitis B or C)
  • If you are taking interferon or ribavirin
  • If you have had previous use of any NRTI class medicine
  • If you have been tested and know whether or not you have a gene variation called HLA-B*5701
  • If you are pregnant, or planning to become pregnant, breastfeeding or planning to breastfeed

    • About all the medicines you are taking including vitamins, herbal supplements and nonprescription drugs

Other Special Warnings

Your blood sugar levels (glucose) or levels of fats (lipids) in your blood may increase with HIV treatment. Your doctor may order blood tests for you.

The class of medicines to which TRIZIVIR belongs (NRTIs), can cause a condition called lactic acidosis (excess of lactic acid in your blood), together with an enlarged liver. Symptoms of lactic acidosis include feeling of weakness, loss of appetite, sudden unexplained weight loss, upset stomach and difficulty breathing or rapid breathing. This rare but serious side effect occurs more often in women. If you have liver disease you may also be more at risk of getting this condition. While you are being treated with TRIZIVIR, your doctor will monitor you closely for any signs that you may be developing lactic acidosis.

Zidovudine, one of the three active ingredients in TRIZIVIR, may also cause a decrease in certain types of blood counts (including red blood cells, white blood cells and platelets) and an increase in certain liver enzymes.

Zidovudine can affect the production of red blood cells, resulting in anemia. If this happens, the symptoms are tiredness and shortness of breath. Less commonly, the production of a certain type of white blood cell may be reduced which can make you more prone to infections. Your doctor may want you to have a blood test from time to time to check the blood cell count.

If you have a hepatitis B infection, you should not stop TRIZIVIR without instructions from your doctor, as you may have a recurrence of your hepatitis. This may occur due to suddenly stopping the active ingredient lamivudine in TRIZIVIR.

Some HIV medicines including abacavir may increase your risk of heart attack. If you have heart problems, smoke or suffer from diseases that increase your risk of heart disease such as high blood pressure and diabetes, tell your doctor. Do not stop taking your medication unless you are advised to do so by your doctor.

You may continue to develop other infections and other illnesses associated with HIV disease. You should therefore keep in regular contact with your doctor while taking TRIZIVIR.

TRIZIVIR helps to control your condition but is not a cure for HIV infection. You will need to take it every day.

Unless you suspect you are having an allergic reaction with TRIZIVIR, do not stop taking your medicine without first talking to your doctor.

Treatment with TRIZIVIR has not been shown to reduce the risk of passing HIV infection on to others by sexual contact or by blood transfer. You should continue to use appropriate precautions to prevent this.

Use of this medicine during pregnancy and breastfeeding:

If you are pregnant, or planning to become pregnant soon, you must inform your doctor before taking any medicine. The safe use of TRIZIVIR in pregnancy has not been established. Your doctor will decide whether you should continue to be treated with TRIZIVIR if you are pregnant. If you take TRIZIVIR while you are pregnant, talk to your doctor about how you can be included in the Antiretroviral Pregnancy Registry.

Babies and infants exposed to Nucleoside Reverse Transcriptase Inhibitors (NRTIs) during pregnancy or labour show minor temporary increases in blood levels of lactate. The clinical importance of these temporary increases is unknown.

These findings do not affect current recommendations to use antiretroviral therapy in pregnant women to prevent transmission of HIV to their babies. There have been very rare reports of disease that affect the neonatal (babies) nervous system such as delayed development and seizures. The long term effects of TRIZIVIR are not known.

It is recommended that HIV infected women do not breastfeed their infants under any circumstances in order to avoid transmission of HIV from mother to child. All three of the active substances in TRIZIVIR are likely to be found in breast milk.

You are recommended not to breastfeed your baby while taking TRIZIVIR.

Remember: This medicine is for you. Never give it to someone else. It may harm them even if their symptoms are the same as yours.

INTERACTIONS WITH THIS MEDICATION

Some drugs may change the usefulness and safety of TRIZIVIR. It is important that your doctor knows about all your medicines so that you get the best possible treatment. Tell your doctor about all your medicines, including vitamin supplements, herbal remedies or homeopathic remedies, including those you have bought yourself.

TRIZIVIR should not be taken with stavudine or emtricitabine.

It is important to tell your doctor or pharmacist about all the medicines listed below or any that you are taking or have recently taken, including those you have bought yourself:

  • Phenytoin, valproic acid, oxazepam, lorazepam
  • Acetylsalicylic acid
  • Codeine, morphine, methadone, rifampicin, indomethacine, ketoprofen, naproxen, cimetidine, clofibrate, Isoprinosine, probenecid
  • Pentamine, pyrimethamine, co-trimoxazole, dapsone, atovaquone, amphotericin, flucytosine, interferon
  • Vincristine, vinblastine, adriamycin and doxorubicin
  • Clarithromycin
  • Fluconazole
  • Ganciclovir
  • Retinoids
  • Methadone
  • Trimethoprim sulphamethoxazole (co-trimoxazole)
  • Interferon and/or ribavirin
  • Sorbitol-containing medicines (usually liquids) used regularly

If you are taking methadone, your doctor may need to adjust your methadone dose, as abacavir increases the rate at which methadone leaves your body. This is unlikely to affect most methadone users.

In men, alcohol does increase the amount of abacavir in your blood. However, the meaning of this is unknown. This interaction had not been studied in women.

PROPER USE OF THIS MEDICATION

Usual dose:

Take TRIZIVIR exactly as your doctor has advised you, and try not to miss any doses. The usual dose is one tablet twice a day. Swallow the tablet whole with water. TRIZIVIR can be taken with or without food. TRIZIVIR is a set (fixed) dose combination of abacavir sulfate, lamivudine and zidovudine and therefore cannot be dose-reduced. If you have kidney or liver problems or if you weigh less than 40 kg, then your medicine may be changed to the separate medicines, ZIAGEN, 3TC and RETROVIR (AZT). If you are unsure about how to take it, ask your doctor or pharmacist. The use of TRIZIVIR has not been established in patients less than 18 years of age, and in elderly patients (> 65 years).

If you are also taking clarithromycin, your doctor may advise you to take this medication at least 2 hours before or 2 hours after TRIZIVIR, to avoid a drug interaction.

Overdose:

If you are concerned that you may have taken too much TRIZIVIR, contact a health care practitioner, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

Missed Dose:

It is important to take this medicine as prescribed to ensure you get maximum benefit. If you forget to take a dose, take it as soon as you remember, and then continue as before. Do not take a double dose to make up for forgotten individual doses.

If you stopped taking TRIZIVIR:

If you stop taking TRIZIVIR because of side effects or illness, you must contact your doctor before restarting to make sure that symptoms of a hypersensitivity reaction have not been missed. In some cases your doctor will ask you to restart TRIZIVIR under direct medical supervision or in a place where you will be able to get ready access to medical care if needed.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Like all medicines, TRIZIVIR can have side effects. When treating HIV infection, it is not always possible to tell whether some of the undesirable effects that occur are caused by TRIZIVIR, by other medicines you are taking at the same time or by the HIV infection. For this reason it is very important that you inform your doctor about any changes in your health.

A hypersensitivity reaction (serious allergic reaction) has been reported in patients who have been treated with abacavir. This is described in the section on Hypersensitivity Reaction (under WARNINGS AND PRECAUTIONS) in the beginning of this leaflet. It is important that you read and understand the information about this serious reaction.

TRIZIVIR contains three active ingredients. Therefore, all side effects that have been reported in patients taking these medicines separately may also occur in patients taking TRIZIVIR. The most common side effects reported for these active ingredients (abacavir, lamivudine and zidovudine) are in bold text:

  • Nausea, vomiting, stomach pain, diarrhea, loss of appetite, flatulence and indigestion.
  • Headache, dizziness, numbness, tingling sensation or sensation of weakness in the limbs, convulsions (fits),

    • difficultly sleeping, tiredness, anxiety, depression, general feeling of being unwell.
    • Cough, breathlessness.
    • Disease of heart muscle (cardiomyopathy)
    • Joint pain, muscle pain and inflammation, including rare reports of breakdown of muscle tissue.
    • Fatigue, fever, malaise and lethargy. Taste changes, chills, urinary frequency, enlargement of the breasts in men, chest pain, flu-like symptoms.
    • Nail and skin colour changes, patchy colour changes in the mouth, rash, very rare reports of serious skin reactions, itching, sweating and hair loss.
    • Liver disorders such as an enlarged liver, fatty liver and jaundice. Temporary increases in certain substance (enzymes) produced by the liver. Inflammation of the pancreas.
    • Anemia (low red blood cell count) and neutropenia/leucopenia (low white blood cell count) have been reported. If the production of red blood cells is reduced you may have symptoms of tiredness or breathlessness. A reduction in your white blood cell count can make you more prone to infection.
    • Reduction in platelets (blood cells important for blood clotting) has been reported. If you have a low platelet count you may notice that you bruise more easily.

Treatment with TRIZIVIR or other medicines that contain zidovudine may cause a loss of fat from legs, arms and face (lipoatrophy). Your doctor should monitor for signs of lipoatrophy. Tell your doctor if you notice any loss of fat from your legs, arms, and face. When these signs occur, your doctor will assess if TRIZIVIR should be stopped and your HIV treatment changed. If you stop taking TRIZIVIR, it may take several months to see any lost fat return. You may not regain all of your lost body fat.

Changes to your immune system (Immune Reconstitution Inflammatory Syndrome) can happen when you start taking HIV-1 medicines. Your immune system may get stronger and begin to fight infections that have been hidden in your body for a long time.

Autoimmune disorders (when the immune system attacks healthy body tissue), may also occur after you start taking medicines for HIV infection. Examples of this include: Grave's disease (which affects the thyroid gland), Guillain-Barré syndrome (which affects the nervous system), polymyositis (which affects the muscles), or autoimmune hepatitis (which affects the liver). Autoimmune disorders may occur many months after the start of treatment. Look for any other symptoms such as:

  • High temperature (fever), redness, rash or swelling
  • Fatigue
  • Joint or muscle pain
  • Numbness or weakness beginning in the hands and feet and moving up towards the trunk of the body
  • Palpitations (chest pain) or rapid heart rate
  • Yellowing of the eyes and skin

If you notice these or any symptoms of inflammation or infection, tell your doctor immediately.

Inflammation in the pancreas (pancreatitis) has been observed in patients treated with abacavir, lamivudine and zidovudine, although it was not clear whether this was due to the medicine or the HIV infection itself (See Side Serious Side Effects table). If your doctor detects clinical signs, symptoms or lab tests suggestive of pancreatitis, they will stop treatment with TRIZIVIR immediately.

Always tell your doctor or pharmacist if any of the side effects mentioned becomes severe or troublesome, or if you notice any other side effects not listed in this leaflet.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effectTalk with your doctor or pharmacistStop taking drug and call your doctor or pharmacist
Only if severeIn all cases
CommonHypersensitivity to abacavir: Serious allergic reaction and 2 or more of the following symptoms: fever, skin rash, nausea, vomiting, diarrhea, abdominal pain, severe tiredness, achiness, general ill-feeling, sore throat, shortness of breath.X
UncommonBlood problems and symptoms such as anemia (lowered red blood cell count – resulting in fatigue, breathlessness), low white blood cell countX
SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effectTalk with your doctor or pharmacistStop taking drug and call your doctor or pharmacist
Only if severeIn all cases
(neutropenia – increasing chance of infection) reduced platelets (blood cells important for blood clotting – could increase chance of bruising) and increases in enzymes produced by the liver.
RarePancreatitis (inflammation of the pancreas) and symptoms such as nausea, vomiting, and abdominal pain.X
Lactic acidosis (high level of acid in the blood): Weight loss, fatigue, malaise, abdominal pain, shortness of breath, severe hepatomegaly (swollen and enlarged liver) with symptoms of liver problems such as nausea, vomiting, abdominal pain, weakness and diarrhea.X

HOW TO STORE IT

Store between 15º and 30ºC.

As with all medicines, keep TRIZIVIR out of the reach and sight of children.

Do not take your medicine after the expiry date shown on the bottle and the carton.

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

  • Report online at www.healthcanada.gc.ca/medeffect • Call toll-free at 1-866-234-2345 • Complete a Canada Vigilance Reporting Form and: - Fax toll-free to 1-866-678-6789, or - Mail to: Canada Vigilance Program Health Canada Postal Locator 1908C Ottawa, ON K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect™ Canada Web site at www.healthcanada.gc.ca/medeffect.

NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

This document plus the full product monograph, prepared for health professionals can be found at:

www.viivhealthcare.com

or by contacting the sponsor, ViiV Healthcare ULC at:

245 Boulevard Armand-Frappier

Laval, Quebec

H7V A47

1-877-393-8448

Last revised: July 4, 2019

© 2019 ViiV Healthcare group of companies or its licensor.

Trademarks are owned by or licensed to the ViiV Healthcare group of companies.

INFORMATION FOR PRESCRIBERS:

A copy of the warning card included with the TRIZIVIR carton is shown below.

WARNING CARD

TRIZIVIR (abacavir sulfate/lamivudine/zidovudine) Tablets

Patients taking TRIZIVIR (abacavir sulfate/lamivudine/zidovudine) may develop a hypersensitivity reaction (a serious allergic reaction) which can be life-threatening if you continue to take TRIZIVIR. If you notice two or more of the following sets of symptoms while taking TRIZIVIR, contact your doctor immediately to find out if you should stop taking TRIZIVIR.

SYMPTOM(S)
Group 1Fever
Group 2Rash
Group 3Nausea, vomiting, diarrhea, or abdominal (stomach area) pain
Group 4Generally ill feeling, extreme tiredness or achiness
Group 5Shortness of breath, cough or sore throat

If you have already had this reaction to TRIZIVIR, never take any medicine containing abacavir, such as ZIAGEN (abacavir sulfate), KIVEXA (abacavir sulfate/lamivudine) or TRIUMEQ (dolutegravir/ abacavir/lamivudine) again. If you take any medicine containing abacavir, such as TRIZIVIR, KIVEXA, ZIAGEN or TRIUMEQ again, within hours you may experience a life-threatening lowering of your blood pressure or death.

Carry this card with you at all times.

You should return all of your unused TRIZIVIR to your doctor or pharmacist for proper disposal.

ViiV Healthcare ULC Laval, Quebec H7V 4A7

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02244757

Revision date stated in the text: July 4, 2019

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Trizivir

Rx or OTC
Prescription (Rx)?
DIN 02244757
Schedule(s) PRESCRIPTION
Active ingredient(s) Abacavir (abacavir sulfate) 300 MG, Lamivudine 150 MG, Zidovudine 300 MG
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. J Antiinfectives for systemic use
    1. J05 Antivirals for systemic use
      1. J05A Direct acting antivirals
        1. J05AR Antivirals for treatment of HIV infections, combinations
          1. J05AR04 Zidovudine, lamivudine and abacavir
Company VIIV HEALTHCARE ULC
Current status Cancelled Post Market
Current status date September 17, 2019

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.